CONTINUE TO SITE
OR WAIT null SECS
© 2021 MJH Life Sciences™ and Modern Retina. All rights reserved.
AAO 2020: Study confirms Phase III results for uveitis treatment
November 14, 2020
OT Staff Reports
OT Staff Reports
Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.
Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.